INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 45h ago
House PTR5h ago
SEC 13F5h ago
Robinhood Chain5h ago

Most active filers · 30d

  1. 01Kurtz George0B / 220S220 trades$52.89M
  2. 02SPSaba Capital Management, L.P.66B / 18S · 11 late84 trades$24.31M
  3. 03SJSheena Jonathan0B / 57S57 trades$3.61M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07RJRubinstein Julie0B / 37S37 trades$6.38M
  8. 08SLSpeiser Michael L0B / 35S35 trades$14.00M
  9. 09RARothblatt Martine A0B / 33S33 trades$5.50M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

69,473 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
YM
Yan MingDirector, CHIEF TECHNOLOGY OFFICER
CTKBCytek Biosciences, Inc.
Option exercise
M—
4,108 sh
May 18, 2026May 20, 2026
Page 788 of 1737
← PrevNext →
traded May 18, 2026
+2d
SEC Form 4

Evidence

9
JW
Jiang WenbinDirector, PRESIDENT AND CEO
CTKBCytek Biosciences, Inc.
Option exercise
M—
38.1K sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

9
JW
Jiang WenbinDirector, PRESIDENT AND CEO
CTKBCytek Biosciences, Inc.
Option exercise
M—
38.1K sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

9
YM
Yan MingDirector, CHIEF TECHNOLOGY OFFICER
CTKBCytek Biosciences, Inc.
Option exercise
M—
9,480 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

9
JW
Jiang WenbinDirector, PRESIDENT AND CEO
CTKBCytek Biosciences, Inc.
Tax withholding
F$18K
5,032 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

9
GE
Gessert EricaChief Financial Officer
UPWKUPWORK, INC
Option exercise
M—
37.5K sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

9
JW
Jiang WenbinDirector, PRESIDENT AND CEO
CTKBCytek Biosciences, Inc.
Option exercise
M—
14.7K sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

9
BV
Barnett ValerieCHIEF LEGAL OFFICER
CTKBCytek Biosciences, Inc.
Option exercise
M—
9,435 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

9
BV
Barnett ValerieCHIEF LEGAL OFFICER
CTKBCytek Biosciences, Inc.
Tax withholding
F$9,237
2,602 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

9
MV
Mercado VictorinoDirector
MNTSMomentus Inc.
Grant or award
A—
6,039 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

9
YM
Yan MingDirector, CHIEF TECHNOLOGY OFFICER
CTKBCytek Biosciences, Inc.
Option exercise
M—
3,683 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

9
YM
Yan MingDirector, CHIEF TECHNOLOGY OFFICER
CTKBCytek Biosciences, Inc.
Tax withholding
F$4,345
1,224 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

9
YM
Yan MingDirector, CHIEF TECHNOLOGY OFFICER
CTKBCytek Biosciences, Inc.
Option exercise
M—
4,908 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

9
BP
Busque PhilippeSVP, GLOBAL SALES AND SERVICES
CTKBCytek Biosciences, Inc.
Tax withholding
F$5,055
1,424 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

9
KA
Krummel Christopher ADirector
CTRICenturi Holdings, Inc.
Option exercise
M—
7,338 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

9
YM
Yan MingDirector, CHIEF TECHNOLOGY OFFICER
CTKBCytek Biosciences, Inc.
Tax withholding
F$3,639
1,025 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

9
HC
Hawks CarneyDirector
NONENONEFERRELLGAS PARTNERS L P
Option exercise
M—
12.7K sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

9
BV
Barnett ValerieCHIEF LEGAL OFFICER
CTKBCytek Biosciences, Inc.
Option exercise
M—
5,156 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

9
YM
Yan MingDirector, CHIEF TECHNOLOGY OFFICER
CTKBCytek Biosciences, Inc.
Tax withholding
F$3,262
919 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

9
BP
Busque PhilippeSVP, GLOBAL SALES AND SERVICES
CTKBCytek Biosciences, Inc.
Tax withholding
F$1,342
378 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

9
HC
Hadfield ChrisDirector
MNTSMomentus Inc.
Grant or award
A—
6,039 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

9
BP
Busque PhilippeSVP, GLOBAL SALES AND SERVICES
CTKBCytek Biosciences, Inc.
Tax withholding
F$934
263 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

9
CR
Cole RyanChief Operating Officer
AUPHAurinia Pharmaceuticals Inc.
Grant or award
A—
116.1K sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

9
BV
Barnett ValerieCHIEF LEGAL OFFICER
CTKBCytek Biosciences, Inc.
Tax withholding
F$3,128
881 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

9
RJ
Reiners Linda J.Director
MNTSMomentus Inc.
Grant or award
A—
6,039 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

9
GE
Gessert EricaChief Financial Officer
UPWKUPWORK, INC
Option exercise
M—
8,524 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

9
KB
Kugler Mitchel B.Director
MNTSMomentus Inc.
Grant or award
A—
6,039 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

9
MD
McCombe William D.Chief Financial Officer
CTKBCytek Biosciences, Inc.
Option exercise
M—
10.7K sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

9
BV
Barnett ValerieCHIEF LEGAL OFFICER
CTKBCytek Biosciences, Inc.
Tax withholding
F$12K
3,386 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

9
BV
Barnett ValerieCHIEF LEGAL OFFICER
CTKBCytek Biosciences, Inc.
Option exercise
M—
2,454 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

9
JW
Jiang WenbinDirector, PRESIDENT AND CEO
CTKBCytek Biosciences, Inc.
Tax withholding
F$13K
3,588 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

9
MK
Motlagh KatherineDirector
EVGOEVgo Inc.
Grant or award
A—
63.7K sh
May 20, 2026May 20, 2026
traded May 20, 2026
+0dSEC Form 4

Evidence

9
YM
Yan MingDirector, CHIEF TECHNOLOGY OFFICER
CTKBCytek Biosciences, Inc.
Tax withholding
F$8,392
2,364 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

9
NE
Nielsen Steven EDirector
CTRICenturi Holdings, Inc.
Grant or award
A—
5,290 sh
May 19, 2026May 20, 2026
traded May 19, 2026
+1dSEC Form 4

Evidence

9
EW
Evans Andrew WDirector
CTRICenturi Holdings, Inc.
Option exercise
M—
7,338 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

9
JW
Jiang WenbinDirector, PRESIDENT AND CEO
CTKBCytek Biosciences, Inc.
Tax withholding
F$6,791
1,913 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

9
KR
Kappus Anthony RayGM & Chief Operating Officer
UPWKUPWORK, INC
Option exercise
M—
5,114 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

9
BP
Busque PhilippeSVP, GLOBAL SALES AND SERVICES
CTKBCytek Biosciences, Inc.
Tax withholding
F$2,201
620 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

9
DK
Damon Doneene KDirector
RWTREDWOOD TRUST INC
Grant or award
A—
24.8K sh
May 19, 2026May 20, 2026
traded May 19, 2026
+1dSEC Form 4

Evidence

9
JW
Jiang WenbinDirector, PRESIDENT AND CEO
CTKBCytek Biosciences, Inc.
Option exercise
M—
19.3K sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence